Amgen Inc.
AMGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $33,424,000 | $28,190,000 | $26,323,000 | $25,979,000 |
| % Growth | 18.6% | 7.1% | 1.3% | – |
| Cost of Goods Sold | $12,858,000 | $8,415,000 | $6,406,000 | $6,454,000 |
| Gross Profit | $20,566,000 | $19,775,000 | $19,917,000 | $19,525,000 |
| % Margin | 61.5% | 70.1% | 75.7% | 75.2% |
| R&D Expenses | $5,964,000 | $4,784,000 | $4,434,000 | $6,324,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $7,096,000 | $6,179,000 | $5,414,000 | $5,368,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $248,000 | $879,000 | $503,000 | $194,000 |
| Operating Expenses | $13,308,000 | $11,842,000 | $10,351,000 | $11,886,000 |
| Operating Income | $7,258,000 | $7,897,000 | $9,566,000 | $7,639,000 |
| % Margin | 21.7% | 28% | 36.3% | 29.4% |
| Other Income/Exp. Net | -$2,649,000 | -$42,000 | -$2,220,000 | -$938,000 |
| Pre-Tax Income | $4,609,000 | $7,855,000 | $7,346,000 | $6,701,000 |
| Tax Expense | $519,000 | $1,138,000 | $794,000 | $808,000 |
| Net Income | $4,090,000 | $6,717,000 | $6,552,000 | $5,893,000 |
| % Margin | 12.2% | 23.8% | 24.9% | 22.7% |
| EPS | 7.62 | 12.56 | 12.18 | 10.34 |
| % Growth | -39.3% | 3.1% | 17.8% | – |
| EPS Diluted | 7.56 | 12.49 | 12.11 | 10.28 |
| Weighted Avg Shares Out | 541,000 | 535,000 | 538,000 | 570,000 |
| Weighted Avg Shares Out Dil | 541,000 | 538,000 | 541,000 | 573,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,155,000 | $2,875,000 | $1,406,000 | $1,197,000 |
| Depreciation & Amortization | $5,592,000 | $4,071,000 | $3,417,000 | $3,398,000 |
| EBITDA | $13,356,000 | $14,801,000 | $12,169,000 | $11,296,000 |
| % Margin | 40% | 52.5% | 46.2% | 43.5% |